---
title: "Pre-market hot trades in US stocks: Propanc Biopharma pre-market down 10.13%; AngloGold Ashanti pre-market up 8.62%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289762007.md"
description: "Propanc Biopharma pre-market down 10.13%; AngloGold Ashanti pre-market up 8.62%; Freecast pre-market up 259.25%; Gelteq pre-market up 91.95%; VS MEDIA pre-market up 78.08%"
datetime: "2026-06-15T09:47:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289762007.md)
  - [en](https://longbridge.com/en/news/289762007.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289762007.md)
---

# Pre-market hot trades in US stocks: Propanc Biopharma pre-market down 10.13%; AngloGold Ashanti pre-market up 8.62%

**Pre-market Hot Trades in US Stocks**

Propanc Biopharma is down 10.13% in pre-market trading. Based on recent key news:

1.  On June 12, Propanc reached a multi-year research collaboration agreement with the University of Jaén and Granada in Spain to evaluate anti-aging compounds and conduct additional research to support the company's patent applications related to fibrosis and cancer. This news failed to boost the stock price and instead raised market concerns about the company's future profitability, leading to a pre-market decline in stock price.
    
2.  On June 12, market sentiment turned extremely bullish, with high discussion volume among retail investors on Stocktwits. However, some investors believe this is a high-risk bet on short-term retail momentum, resulting in increased stock price volatility.
    
3.  On June 12, Propanc's stock price experienced a super rebound driven by retail investors, but due to market skepticism about its long-term value, the stock price failed to maintain its upward momentum and saw a significant pre-market decline. Market sentiment is volatile, and risks need to be monitored.
    

AngloGold Ashanti is up 8.62% in pre-market trading. Based on recent key news:

1.  On June 12, AngloGold Ashanti announced it would seek shareholder approval for its $2 billion stock buyback plan. This move pushed the stock price up by about 1.5%. Source: AngloGold Ashanti official announcement
    
2.  On June 12, the board of directors approved the buyback plan, but implementation requires shareholder approval and relevant regulatory permissions. This news further boosted market confidence. Source: AngloGold Ashanti official announcement
    
3.  On June 14, despite pressures in the gold mining industry, AngloGold Ashanti maintains a strong balance sheet, attracting investor attention. Source: Simply Wall St The gold mining industry is under pressure, focus on balance sheets.
    

**Top Gainers in Pre-market US Stocks**

Freecast is up 259.25% in pre-market trading. Based on recent key news:

1.  On June 12, FreeCast announced an expanded partnership with DIRECTV, significantly boosting the stock price. This partnership integrates FreeCast's live TV and subscription management platform into DIRECTV's existing channels, enhancing market confidence in its platform, leading to a 100.93% stock price increase;
    
2.  FreeCast's platform PaaS stack is widely used across various sectors, including telecommunications operators, internet service providers, and broadcasters, further enhancing its market value. The platform combines live TV, FAST channels, premium services, local content, advertising, commerce, subscription management, and audience interaction tools, attracting more investor attention;
    
3.  FreeCast's technological innovations and market expansion strategies have received positive feedback from investors, driving a significant increase in stock price. The company provides a unified environment by integrating multiple services and tools, enhancing its market competitiveness. The market responds positively to technological innovations and expansion strategies Gelteq pre-market rose 91.95%. Based on recent key news:
    
4.  On June 12, Gelteq achieved positive results in a veterinary palatability trial in collaboration with Kemin Industries. The trial aimed to enhance the flavor of the product and assess the acceptance of products using Gelteq® technology in canines. The trial results indicated that Gelteq technology has broad commercial potential in veterinary applications, driving the stock price up.
    
5.  On June 12, Gelteq stated that this success strengthened ongoing discussions with potential strategic partners and continued to expand its animal health product line. The company believes this will further enhance its market competitiveness and promote stock price increases.
    
6.  On June 12, Gelteq's stock price surged significantly in pre-market trading, reflecting strong market confidence in its technology and business prospects. Increased demand in the veterinary market and technological innovation drove the stock price up.
    

VS MEDIA, pre-market rose 78.08%, with no significant news recently. Trading is active, and capital flow is evident. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation

### Related Stocks

- [PPCB.US](https://longbridge.com/en/quote/PPCB.US.md)
- [AU.US](https://longbridge.com/en/quote/AU.US.md)
- [CAST.US](https://longbridge.com/en/quote/CAST.US.md)
- [GELS.US](https://longbridge.com/en/quote/GELS.US.md)
- [VSME.US](https://longbridge.com/en/quote/VSME.US.md)

## Related News & Research

- [AngloGold Ashanti PLC $AU Shares Sold by Gabelli Funds LLC](https://longbridge.com/en/news/293819696.md)
- [AngloGold Ashanti shareholders backed off-market share buyback authority at general meeting](https://longbridge.com/en/news/293736720.md)
- [28,761 Shares in AngloGold Ashanti PLC $AU Bought by ABN Amro Investment Solutions](https://longbridge.com/en/news/293715220.md)
- [Result of AngloGold Ashanti plc's General Meeting | AU Stock News](https://longbridge.com/en/news/293738346.md)
- [10:11 ETAU Small Finance Bank Raises FCNR Deposit Rates to 7.40% and NRE Fixed Deposit Rates to 7.60%](https://longbridge.com/en/news/293945743.md)